Return to Trial Database

BTCRC-GI18-149

Phase II Study of the Combination of Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149

Status

Study Completed

Cancer Type(s)

Esophageal Gastric Gastroesophageal Junction

Study Contact

Trial Locations

All sites in which the trial BTCRC-GI18-149 being conducted in.

No data was found